Thank the Rich for Low Rates?

High savings rates among the wealthiest U.S. earners may represent a macroeconomic risk

by Jonathan Shaw

On Firmer Footing

Robust financial results despite the pandemic, and historic endowment returns

by John S. Rosenberg

The Faculty Faces Its Future

Better results than expected during the pandemic, and a sweeping effort to plan for academic improvements

by John S. Rosenberg

News Briefs

Legacies challenged, campus sustainability, affirmative-action litigation, and honored scientists

by John S. Rosenberg

Brevia

No more Harvard Teacher Fellows, universities and slavery, and more

A Just World at Peace

President Bacow on Harvard Divinity School

by Lawrence Bacow

Both Sides Now

Tomiko Brown-Nagin’s bifocal view of the civil-rights movement

by Lincoln Caplan

Chan Zuckerberg Commits $500 Million to Harvard Neuroscience and AI Institute

A 15-year investment in biomedical and applied science research

by Jonathan Shaw

Curating a More Diverse Campus Environment

A report and recommendations, from the FAS task force on signage and visual culture issues 

by Lydialyle Gibson

Against Delta, Moderna Edges Pfizer, but Omicron Looms

A head-to-head comparison in 440,000 vaccinated veterans finds Moderna’s vaccine is slightly more effective than Pfizer’s at preventing a range of COVID-19 outcomes.

by Jonathan Shaw